Regulation of GPCR function by oligomerization

通过寡聚化调节 GPCR 功能

基本信息

项目摘要

G protein-coupled receptor (GPCR) is important for various cellular functions. It is a target for neurotransmission or drug action. For a long time, GPCR has been considered to work as a monomer coupling with various G proteins. Recently, oligomers between GPCRs have been reported, such as GABA_B receptors, adrenergic receptors and dopamine receptors. Because signaling or cellular translocation can be modified by the GPCR oligomerization, GPCR oligomer formation has attracted much attention as a new mechanism for GPCR function. Here, we studied on the oligomerization of G protein-coupled purinergic receptors which are divided into 4 adenosine receptors (A_1, A_<2A>, A_<2B>, A_3) and 8 P2Y receptors (1, 2, 4, 6, 11, 12, 13, 14), known to regulate neurotransmission negatively. The following results were obtained. (1)A_1 and A_<2A> adenosine receptors were found to associate with P2Y receptors, i.e. A_<2A>/P2Y_1, A_<2A>/P2Y_2, A_1/P2Y_1 and A_1/P2Y_2. Electron microscopic observation was … More revealed to be an efficient method for the direct observation of oligomer formation among A_1 and P2Y_2 receptors in both transfected cultured cells and natural tissues where these receptors constitutively express. (2)Cell signaling in the HEK293T cells cotransfected with A_1 adenosine receptor and P2Y_2 receptor was found to be significantly modified. The functional activity of A_1R, as indicated by the G_<i/o>-mediated inhibition of adenylyl cyclase, in the cotransfected cells was attenuated by the simultaneous addition of A_1R and P2Y_2R agonists. The increase in intracellular Ca^<2+> levels induced by P2Y_2R activation of G_<q/11> was synergistically enhanced by the simultaneous addition of an A_1R agonist in the coexpressing cells. These results suggest that oligomerization of A_1R and P2Y_2R generates a unique complex in which the simultaneous activation of the two receptors induces a structural alteration that interferes signaling via G_<i/o> but enhances signaling via G_<q/11>. (3)From these results, oligomer formation among purinergic receptors was found to be important for the regulation of cell function by adenosine/ATP. Less
G蛋白偶联受体(GPCR)对多种细胞功能都很重要。它是神经传递或药物作用的靶点。长期以来,GPCR一直被认为是作为单体与各种G蛋白偶联而起作用。近年来,GPCR之间的寡聚体被报道,如GABA_B受体、肾上腺素能受体和多巴胺受体。由于GPCR寡聚化可以修饰信号传导或细胞转位,因此GPCR寡聚体形成作为GPCR功能的新机制引起了人们的广泛关注。本实验研究了G蛋白偶联的嘌呤能受体的寡聚化,这些受体被分为4种腺苷受体(A_1,<2A>A_3,A_1<2B>,A_3)和8种P_2Y受体(1,2,4,6,11,12,13,14),已知它们负性调节神经传递。获得了以下结果。(1)A A_1和A_2<2A>腺苷受体与P_2Y受体结合,即<2A>A_1/P_2Y_1、A_1<2A>/P_2Y_2、A_1/P_2Y_1和A_1/P_2Y_2。电子显微镜观察 ...更多信息 结果表明,该方法是一种直接观察A_1和P2Y_2受体组成型表达的细胞和自然组织中A_1和P2Y_2受体寡聚体形成的有效方法。(2)A_1腺苷受体和P_2Y_2受体共转染的HEK 293 T细胞的细胞信号转导功能明显改变。同时加入A_1R和P2Y_2R激动剂,可减弱A_1R的功能活性,即G_&lt;i/o&gt;介导的腺苷酸环化酶抑制。在共表达细胞中同时加入A_1 R激动剂可协同增强P2Y_2 R激活G_&lt;q/11&gt;引起的细胞内Ca^&lt;2+&gt;水平的升高。这些结果表明,A_1R和P2Y_2R的寡聚化产生了一个独特的复合物,其中两种受体的同时激活引起了结构的改变,干扰了G_&lt;i/o&gt;信号,但增强了G_&lt;q/11&gt;信号。(3)从这些结果可以看出,嘌呤能受体之间的寡聚体形成对于腺苷/ATP调节细胞功能是重要的。少

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Purinergic receptor complex : generating adenine nucleotide-sensitive adenosine receptors.
嘌呤能受体复合物:产生腺嘌呤核苷酸敏感的腺苷受体。
Regulation of pharmacology by hetero-oligomerization between A_1 adenosine receptor and P2Y_2 receptor.
A_1 腺苷受体和 P2Y_2 受体之间异源寡聚化的药理学调节。
[Heterogeneity of G protein-coupled receptor generated by post-translational mechanisms and its clinical meanings].
翻译后机制产生的G蛋白偶联受体的异质性及其临床意义
Clathrin required for phosphorylation and internalization of beta 2-adrenergic receptor by G protein-coupled receptor kinase 2 (GRK2).
G 蛋白偶联受体激酶 2 (GRK2) 磷酸化和内化 β2-肾上腺素受体所需的网格蛋白。
Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1α
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKATA Hiroyasu其他文献

NAKATA Hiroyasu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKATA Hiroyasu', 18)}}的其他基金

Mechanism of G protein-coupled receptor oligomerization
G蛋白偶联受体寡聚化机制
  • 批准号:
    19036036
  • 财政年份:
    2007
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Research on THz laser utilizing deep impurities in semiconductors
利用半导体深层杂质的太赫兹激光器研究
  • 批准号:
    17540297
  • 财政年份:
    2005
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on Contract under the New Regime of Insolvency Law
破产法新制度下的合同研究
  • 批准号:
    16530052
  • 财政年份:
    2004
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Expression and function of hetereomeric purinergic receptors
异聚嘌呤能受体的表达和功能
  • 批准号:
    13670109
  • 财政年份:
    2001
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structure and function of a new purinergic receptor
新型嘌呤受体的结构和功能
  • 批准号:
    10670104
  • 财政年份:
    1998
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
STUDIES ON THE MOLECULAR MECHANISM OF CELLULAR TRANSDUCTION VIA ADENOSINE RECEPTORS
腺苷受体细胞转导的分子机制研究
  • 批准号:
    06680638
  • 财政年份:
    1994
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies on the molecular mechanism of cellular signal transduction via adenosine receptors
腺苷受体细胞信号转导分子机制研究
  • 批准号:
    04454603
  • 财政年份:
    1992
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

超高亲和力、高亮度 Dimer 荧光 RNA 探针用于活细胞 RNA 单分子成像
  • 批准号:
    24ZR1432500
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
靶向肝细胞癌glypican-3的新型68Ga/177Lu-DOTA-3PEGn-TJ12P2 Dimer诊疗一体化探针的初步研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
图的生成树、纽结行列式与Kenyon猜想
  • 批准号:
    11701401
  • 批准年份:
    2017
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
若干格子图的研究
  • 批准号:
    11701324
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
血浆D-dimer检测恶性肿瘤血行微转移的临床价值评估及机制研究
  • 批准号:
    81501826
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
统计模型中的若干组合问题
  • 批准号:
    11171134
  • 批准年份:
    2011
  • 资助金额:
    45.0 万元
  • 项目类别:
    面上项目
图的Pfaffian定向与完美匹配的计数
  • 批准号:
    10771086
  • 批准年份:
    2007
  • 资助金额:
    22.0 万元
  • 项目类别:
    面上项目
稀疏矩阵积和式的算法研究及其在物理、化学中的应用
  • 批准号:
    10501030
  • 批准年份:
    2005
  • 资助金额:
    15.0 万元
  • 项目类别:
    青年科学基金项目
Dimer 系统的非平衡统计问题
  • 批准号:
    10175008
  • 批准年份:
    2001
  • 资助金额:
    13.0 万元
  • 项目类别:
    面上项目

相似海外基金

Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
  • 批准号:
    10751480
  • 财政年份:
    2024
  • 资助金额:
    $ 9.73万
  • 项目类别:
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
CAS: Heteroatom Dimer and Cluster Catalysis
CAS:杂原子二聚体和簇催化
  • 批准号:
    2247571
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Standard Grant
Establishment of highly selective production method of metal nanoparticle dimer using plasmon induced chemical reaction
利用等离子体诱导化学反应高选择性生产金属纳米粒子二聚体的方法的建立
  • 批准号:
    22KJ2306
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Mitochondrial Calcium and Neuronal Health
线粒体钙和神经元健康
  • 批准号:
    10638869
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology
代谢型谷氨酸受体异聚化对信号传导和药理学的影响
  • 批准号:
    10637938
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
  • 批准号:
    10638439
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
  • 批准号:
    10667987
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
The roles of AP-1 pathway activation in NK cell development and exhaustion programming in AML
AP-1 通路激活在 NK 细胞发育和 AML 衰竭编程中的作用
  • 批准号:
    10751755
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
研究体细胞线粒体常见缺失的影响和动态
  • 批准号:
    10826448
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了